NCT06783192View on ClinicalTrials.gov

A Drug-Drug Interaction Study of MK 8527 With a Combined Oral Contraceptive (LNG/EE)

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

August 14, 2023

Primary Completion Date

October 11, 2023

Study Completion Date

October 11, 2023

Conditions
Human Immunodeficiency Virus (HIV)HIV Pre-Exposure Prophylaxis
Interventions
DRUG

MK-8527

MK-8527 capsule taken by mouth

DRUG

LNG/EE

LNG/EE combination tablet taken by mouth.

Trial Locations (1)

33143

QPS-MRA, LLC-Early Phase (Site 0001), South Miami

All Listed Sponsors
lead

Merck Sharp & Dohme LLC

INDUSTRY